Stealth BioTherapeutics Corp - ADR

NASDAQ:MITO   3:54:21 PM EDT
0.22
-0.01 (-4.19%)
Products

Stealth Biotherapeutics Receives Orphan Drug Designation From FDA For Elamipretide For The Treatment Of Friedreich's Ataxia

Published: 03/28/2022 11:47 GMT
Stealth BioTherapeutics Corp - ADR (MITO) - Stealth Biotherapeutics Receives Orphan Drug Designation From FDA for Elamipretide for the Treatment of Friedreich's Ataxia.